A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer

Jeremy Cetnar, George Wilding, Douglas McNeel, Noelle K. LoConte, Thomas A. McFarland, Jens Eickhoff, Glenn Liu

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences